H2 haplotype and atherosclerosis

H2单倍型与动脉粥样硬化

基本信息

  • 批准号:
    8240933
  • 负责人:
  • 金额:
    $ 23.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-12-15 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Radiation is a risk factor for atherosclerotic cardiovascular disease. However, little is known about the mechanisms that underlie radiation-enhanced atherosclerosis. Our recent studies have identified H2, the murine MHC, as a major genetic determinant of susceptibility to radiation-enhanced atherosclerosis. C3H/HeJ (C3H) mice are extremely resistant to atherosclerosis, developing much smaller lesions than C57BL/6 (B6) mice when deficient in apolipoprotein E (apoE-/-) or fed an atherogenic diet. The two strains differ in the H2 haplotype with B6 having H2b and C3H having H2k. C3.SW-H2b/SnJ (C3.SW) is a congenic strain of C3H/HeJ in which the H2k locus is replaced with H2b. Surprisingly, C3.SW.apoE-/- mice that underwent bone marrow transplantation after lethal irradiation exhibited a 21-fold increase in atherosclerotic lesion size relative to C3H.apoE-/- mice receiving the same treatment, demonstrating the dramatic impact of H2 haplotypes on atherosclerosis. We will use this novel C3.SW.apoE-/- mouse model to investigate mechanistic links between H2 haplotypes and plaque formation. We will also test a promising candidate gene in the H2 region. MDC1, encoding the mediator of DNA damage checkpoint 1, is a component of the genome surveillance network activated by DNA double-strand breaks. Multiple SNPs have been detected in both coding and regulatory regions of MDC1 between H2b and H2k haplotypes. We will determine whether deficiency in MDC1 would promote atherosclerosis following radiation. These studies will shed light on new genes and new pathways that control atherosclerosis susceptibility. PUBLIC HEALTH RELEVANCE: Radiation therapy or radiotherapy is the most important non-surgical modality for the treatment of cancer and many proliferating, non-malignant conditions. However, patients receiving radiotherapy have an increased risk of developing atherosclerotic cardiovascular disease. The objective of this project is to identify genes in the major histocompatibility complex (MHC) region that have a dramatic influence on radiation-induced atherosclerosis.
描述(由申请人提供):辐射是动脉粥样硬化性心血管疾病的危险因素。然而,人们对辐射增强动脉粥样硬化的机制知之甚少。我们最近的研究已经确定H2,即小鼠MHC,是辐射增强动脉粥样硬化易感性的主要遗传决定因素。C3H/HeJ (C3H)小鼠对动脉粥样硬化具有很强的抵抗力,在缺乏载脂蛋白E (apoE-/-)或喂食致动脉粥样硬化饮食时,C57BL/6 (B6)小鼠的病变要小得多。这两个菌株的H2单倍型不同,B6有H2b, C3H有H2k。C3。SW-H2b/SnJ (C3.SW)是C3H/HeJ的同源菌株,其中H2k位点被H2b取代。令人惊讶的是,C3.SW。在致死性照射后进行骨髓移植的apoE-/-小鼠,其动脉粥样硬化病变的大小比C3H增加了21倍。apoE-/-小鼠接受相同的治疗,证明H2单倍型对动脉粥样硬化的显著影响。我们将使用这本新奇的C3.SW。apoE-/-小鼠模型研究H2单倍型与斑块形成之间的机制联系。我们还将在H2区测试一个有希望的候选基因。MDC1编码DNA损伤检查点1的中介,是DNA双链断裂激活的基因组监测网络的一个组成部分。在MDC1的H2b和H2k单倍型之间的编码区和调控区都检测到多个snp。我们将确定MDC1缺乏是否会促进放疗后动脉粥样硬化。这些研究将揭示控制动脉粥样硬化易感性的新基因和新途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WEIBIN SHI其他文献

WEIBIN SHI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WEIBIN SHI', 18)}}的其他基金

Genetic connections between type 2 diabetes and atherosclerosis
2 型糖尿病与动脉粥样硬化之间的遗传联系
  • 批准号:
    10080725
  • 财政年份:
    2019
  • 资助金额:
    $ 23.1万
  • 项目类别:
Genetic connections between type 2 diabetes and atherosclerosis
2 型糖尿病与动脉粥样硬化之间的遗传联系
  • 批准号:
    10319991
  • 财政年份:
    2019
  • 资助金额:
    $ 23.1万
  • 项目类别:
Genetic link between type 2 diabetes and atherosclerosis
2 型糖尿病与动脉粥样硬化之间的遗传联系
  • 批准号:
    8584827
  • 财政年份:
    2013
  • 资助金额:
    $ 23.1万
  • 项目类别:
Genetic link between type 2 diabetes and atherosclerosis
2 型糖尿病与动脉粥样硬化之间的遗传联系
  • 批准号:
    8849904
  • 财政年份:
    2013
  • 资助金额:
    $ 23.1万
  • 项目类别:
Genetic link between type 2 diabetes and atherosclerosis
2 型糖尿病与动脉粥样硬化之间的遗传联系
  • 批准号:
    8695343
  • 财政年份:
    2013
  • 资助金额:
    $ 23.1万
  • 项目类别:
H2 haplotype and atherosclerosis
H2单倍型与动脉粥样硬化
  • 批准号:
    8399045
  • 财政年份:
    2011
  • 资助金额:
    $ 23.1万
  • 项目类别:
Serum amyloid P and chronic noncommunicable diseases
血清淀粉样蛋白 P 与慢性非传染性疾病
  • 批准号:
    7833108
  • 财政年份:
    2009
  • 资助金额:
    $ 23.1万
  • 项目类别:
Serum amyloid P and chronic noncommunicable diseases
血清淀粉样蛋白 P 与慢性非传染性疾病
  • 批准号:
    7933874
  • 财政年份:
    2009
  • 资助金额:
    $ 23.1万
  • 项目类别:
Genetic analysis of neointimal hyperplasia
新生内膜增生的遗传分析
  • 批准号:
    7436143
  • 财政年份:
    2007
  • 资助金额:
    $ 23.1万
  • 项目类别:
Genetic analysis of neointimal hyperplasia
新生内膜增生的遗传分析
  • 批准号:
    7264208
  • 财政年份:
    2007
  • 资助金额:
    $ 23.1万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了